Qiligeer Bao
- Cardiology and Cardiovascular Medicine
- Endocrinology, Diabetes and Metabolism
- Epidemiology
- Physiology
- Public Health, Environmental and Occupational Health
- Topics
- Blood Pressure and Hypertension Studies (6 papers)Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers)Cardiovascular Health and Disease Prevention (6 papers)
- Journals
- PLoS ONEScientific ReportsSLEEP
- Partner nations
- ChinaTaiwanUnited States
In The Last Decade
Qiligeer Bao
18 papers receiving 228 citations
Peers
Comparison fields: 5 of 52
- Cardiology and Cardiovascular Medicine 94
- Endocrinology, Diabetes and Metabolism 67
- Epidemiology 52
- Physiology 44
- Public Health, Environmental and Occupational Health 42
Countries citing papers authored by Qiligeer Bao
This map shows the geographic impact of Qiligeer Bao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qiligeer Bao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qiligeer Bao more than expected).
Fields of papers citing papers by Qiligeer Bao
This network shows the impact of papers produced by Qiligeer Bao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qiligeer Bao. The network helps show where Qiligeer Bao may publish in the future.
Co-authorship network of co-authors of Qiligeer Bao
This figure shows the co-authorship network connecting the top 25 collaborators of Qiligeer Bao. A scholar is included among the top collaborators of Qiligeer Bao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qiligeer Bao. Qiligeer Bao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 0 | |
| 5 | 1 | |
| 6 | 2 | |
| 7 | 3 | |
| 8 | 2 | |
| 9 | 15 | |
| 10 | 32 | |
| 11 | 23 | |
| 12 | 60 | |
| 13 | 25 | |
| 14 | 2 | |
| 15 | 11 | |
| 16 | 5 | |
| 17 | 2 | |
| 18 | 16 | |
| 19 | 26 | |
| 20 | 1 |
About Qiligeer Bao
Qiligeer Bao is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Nephrology, having authored 21 papers that have together received 230 indexed citations. Recurring topics across this work include Blood Pressure and Hypertension Studies (6 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers) and Cardiovascular Health and Disease Prevention (6 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (94 citations), Endocrinology, Diabetes and Metabolism (67 citations) and Nephrology (22 citations). Qiligeer Bao has collaborated with scholars based in China, Taiwan and United States. Frequent co-authors include Shuang Cai, Bokai Cheng, Anhang Zhang, Shouyuan Ma, Yongkang Su, Shuxia Wang, Jin Sun, Man Li, Yan Zhang and Man Li. Their work appears in journals such as PLoS ONE, Scientific Reports and SLEEP.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.